{"id":2777,"date":"2024-05-05T04:39:03","date_gmt":"2024-05-05T04:39:03","guid":{"rendered":"https:\/\/apellismedicalhub.ca\/fr\/?page_id=2777"},"modified":"2024-05-29T15:36:33","modified_gmt":"2024-05-29T15:36:33","slug":"association-for-research-in-vision-and-ophthalmology-arvo-2024","status":"publish","type":"page","link":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/","title":{"rendered":"Association for Research in Vision and Ophthalmology (ARVO) 2024"},"content":{"rendered":"\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='av_section_1'  class='avia-section av-bkbqv-9901f7abcac0ec6a48600d7897426235 main_color avia-section-default avia-no-border-styling  avia-builder-el-1  el_after_av_codeblock  el_before_av_section  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2777'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lcopzbru-69e3b6c896ed4428e7730a96f436c5af\">\n#top .av-special-heading.av-lcopzbru-69e3b6c896ed4428e7730a96f436c5af{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-lcopzbru-69e3b6c896ed4428e7730a96f436c5af .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-lcopzbru-69e3b6c896ed4428e7730a96f436c5af .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-lcopzbru-69e3b6c896ed4428e7730a96f436c5af av-special-heading-h3  avia-builder-el-2  el_before_av_textblock  avia-builder-el-first  detail-header'><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Association for Research in Vision and Ophthalmology (ARVO) 2024<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lcopqxoc-3ec3404e4084d8acaf8a79a0cae439b6\">\n#top .av_textblock_section.av-lcopqxoc-3ec3404e4084d8acaf8a79a0cae439b6 .avia_textblock{\nfont-size:18px;\n}\n<\/style>\n<section  class='av_textblock_section av-lcopqxoc-3ec3404e4084d8acaf8a79a0cae439b6 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><p class=\"u-font-weight-bold u-mb-0\">Long-term efficacy and safety of pegcetacoplan over 36 months: results from 12 months of the GALE open-label extension study<\/p>\n<p class=\"u-font-weight-bold u-mb-0\"><strong><a class=\"c-link-expand\" title=\"Access Resources\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/long-term-efficacy-and-safety-of-pegcetacoplan-over-36-months-results-from-12-months-of-the-gale-open-label-extension-study-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p class=\"u-font-weight-bold u-mb-0\">SD-OCT and Fundus Autofluorescence in geographic atrophy: a comprehensive point-to-point correlation of FAF and SD-OCT using the phase III DERBY and OAKS trials<\/p>\n<p class=\"u-font-weight-bold u-mb-0\"><strong><a class=\"c-link-expand\" title=\"Access Resources\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/sd-oct-and-fundus-autofluorescence-in-geographic-atrophy-a-comprehensive-point-to-point-correlation-of-faf-and-sd-oct-using-the-phase-iii-derby-and-oaks-trials-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p class=\"u-font-weight-bold u-mb-0\">Variability of perilesional FAF patterns associated with automated OCT-based PR\/RPE loss ratios in GA progression in the phase 3 OAKS\/DERBY trials<\/p>\n<p class=\"u-font-weight-bold u-mb-0\"><strong><a class=\"c-link-expand\" title=\"Access Resources\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/variability-of-perilesional-faf-patterns-associated-with-automated-oct-based-pr-rpe-loss-ratios-in-ga-progression-in-the-phase-3-oaks-derby-trials-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p class=\"u-font-weight-bold u-mb-0\">Contrast sensitivity function using a prototype gaze tracking-based virtual reality headset in age-related macular degeneration<\/p>\n<p class=\"u-font-weight-bold u-mb-0\"><strong><a class=\"c-link-expand\" title=\"Access Resources\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/contrast-sensitivity-function-using-a-prototype-gaze-tracking-based-virtual-reality-headset-in-age-related-macular-degeneration-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Prevalence of outer retinal tubulation (ORT) and association with geographic atrophy (GA) lesion growth among GA patients in the OAKS and DERBY trials<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"Access Resources\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/prevalence-of-outer-retinal-tubulation-ort-and-association-with-geographic-atrophy-ga-lesion-growth-among-ga-patients-in-the-oaks-and-derby-trials-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/a-deep-learning-approach-to-identifying-quantitative-oct-biomarkers-predictive-of-visual-deficit-measured-by-microperimetry-at-24-months-in-oaks-trial-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/ai-based-qoct-analysis-of-phase-iii-trials-oaks-derby-data-on-the-effect-of-pegcetacoplan-on-geographic-atrophy-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Predictive value of the photoreceptor\/RPE loss ratio on OCT in the management of geographic atrophy (GA) for patient selection and monitoring of therapeutic efficacy<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/predictive-value-of-the-photoreceptor-rpe-loss-ratio-on-oct-in-the-management-of-geographic-atrophy-ga-for-patient-selection-and-monitoring-of-therapeutic-efficacy-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Loss of independence in geographic atrophy: results from the MOSAIC study among patients and their caregivers in Europe, Canada, and Australia<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/loss-of-independence-in-geographic-atrophy-results-from-the-mosaic-study-among-patients-and-their-caregivers-in-europe-canada-and-australia-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Deep learning based segmentation of geographic atrophy in fundus autofluorescence: external validation in imaging acquired in a clinical trial<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/deep-learning-based-segmentation-of-geographic-atrophy-in-fundus-autofluorescence-external-validation-in-imaging-acquired-in-a-clinical-trial-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Pegcetacoplan vs avacincaptad pegol in geographic atrophy: an anchored matching-adjusted indirect comparison of three phase 3 trials<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/pegcetacoplan-vs-avacincaptad-pegol-in-geographic-atrophy-an-anchored-matching-adjusted-indirect-comparison-of-three-phase-3-trials-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Rate of response to treatment in eyes with GA treated with Pegcetacoplan in a within-patient comparison using automated AI-based OCT biomarker quantifications in OAKS and DERBY<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/rate-of-response-to-treatment-in-eyes-with-ga-treated-with-pegcetacoplan-in-a-within-patient-comparison-using-automated-ai-based-oct-biomarker-quantifications-in-oaks-and-derby-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>IRIS\u00ae Registry\u202fanalysis of anti-VEGF treatment in patients with coexisting neovascular age-related macular degeneration and geographic atrophy<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/iris-registry-analysis-of-anti-vegf-treatment-in-patients-with-coexisting-neovascular-age-related-macular-degeneration-and-geographic-atrophy-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p>Pegcetacoplan delays time to development of central scotoma loss of central macular sensitivity: a microperimetry analysis of the phase 3 OAKS study<\/p>\n<p><strong><a class=\"c-link-expand\" title=\"AI-based qOCT analysis of phase-III trials OAKS &amp; DERBY data on the effect of pegcetacoplan on geographic atrophy (ARVO 2024 GA)\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/pegcetacoplan-delays-time-to-development-of-central-scotoma-loss-of-central-macular-sensitivity-a-microperimetry-analysis-of-the-phase-3-oaks-study-arvo-2024\/\" target=\"_blank\" rel=\"noopener\">Access Resources<\/a><\/strong><\/p>\n<p class=\"u-font-weight-bold u-mb-0\">\n<\/div><\/section>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lcoriyd8-c1881a78f513690221d6bf6996b633bf\">\n#top .hr.hr-invisible.av-lcoriyd8-c1881a78f513690221d6bf6996b633bf{\nheight:20px;\n}\n<\/style>\n<div  class='hr av-lcoriyd8-c1881a78f513690221d6bf6996b633bf hr-invisible  avia-builder-el-4  el_after_av_textblock  avia-builder-el-last '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div>\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='av_section_2'  class='avia-section av-7zfbb-bc9f554885a6613776ac7a01ce1159cf main_color avia-section-default avia-no-border-styling  avia-builder-el-5  el_after_av_section  avia-builder-el-last  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2777'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lcoqequv-ae1aaf697da671fa2245d918d2ca9e2a\">\n#top .hr.av-lcoqequv-ae1aaf697da671fa2245d918d2ca9e2a{\nmargin-top:10px;\nmargin-bottom:20px;\n}\n.hr.av-lcoqequv-ae1aaf697da671fa2245d918d2ca9e2a .hr-inner{\nwidth:100%;\nborder-color:#515151;\n}\n<\/style>\n<div  class='hr av-lcoqequv-ae1aaf697da671fa2245d918d2ca9e2a hr-custom  avia-builder-el-6  el_before_av_textblock  avia-builder-el-first  hr-center hr-icon-no'><span class='hr-inner inner-border-av-border-thin'><span class=\"hr-inner-style\"><\/span><\/span><\/div>\n<section  class='av_textblock_section av-lcorkljc-07f2177690d5573cc59beb45c59b52f8 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><p>The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.<\/p>\n<\/div><\/section>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":0,"parent":338,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2777","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada\" \/>\n<meta property=\"og:url\" content=\"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Apellis Medical Hub Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-29T15:36:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/association-for-research-in-vision-and-ophthalmology-arvo-2024\\\/\",\"url\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/association-for-research-in-vision-and-ophthalmology-arvo-2024\\\/\",\"name\":\"Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/#website\"},\"datePublished\":\"2024-05-05T04:39:03+00:00\",\"dateModified\":\"2024-05-29T15:36:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/association-for-research-in-vision-and-ophthalmology-arvo-2024\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/association-for-research-in-vision-and-ophthalmology-arvo-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/association-for-research-in-vision-and-ophthalmology-arvo-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geographic Atrophy GA\",\"item\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/geographic-atrophy-ga\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Association for Research in Vision and Ophthalmology (ARVO) 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/\",\"name\":\"Apellis Medical Hub Canada\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/apellismedicalhub.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada","og_url":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/","og_site_name":"Apellis Medical Hub Canada","article_modified_time":"2024-05-29T15:36:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/","url":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/","name":"Association for Research in Vision and Ophthalmology (ARVO) 2024 - Apellis Medical Hub Canada","isPartOf":{"@id":"https:\/\/apellismedicalhub.ca\/fr\/#website"},"datePublished":"2024-05-05T04:39:03+00:00","dateModified":"2024-05-29T15:36:33+00:00","breadcrumb":{"@id":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/association-for-research-in-vision-and-ophthalmology-arvo-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/apellismedicalhub.ca\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Geographic Atrophy GA","item":"https:\/\/apellismedicalhub.ca\/fr\/geographic-atrophy-ga\/"},{"@type":"ListItem","position":3,"name":"Association for Research in Vision and Ophthalmology (ARVO) 2024"}]},{"@type":"WebSite","@id":"https:\/\/apellismedicalhub.ca\/fr\/#website","url":"https:\/\/apellismedicalhub.ca\/fr\/","name":"Apellis Medical Hub Canada","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/apellismedicalhub.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/pages\/2777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/comments?post=2777"}],"version-history":[{"count":0,"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/pages\/2777\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/pages\/338"}],"wp:attachment":[{"href":"https:\/\/apellismedicalhub.ca\/fr\/wp-json\/wp\/v2\/media?parent=2777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}